|
|
[RegAffairs]Re: Analytical method for unspecified & totalimpurities
It is necessary but the reasons differ depending on the jurisdiction that you are operating in. For example, outside of the US, the USP monograph has little relevance. Inside the US, you still need permission to sell and that comes from the FDA who will require that your product also complies with requirements for stability etc as described in the various ICH guidances. So the USP monograph becomes a relatively minor issue. Malcolm Ross Generapharm-TC Basel-CH |
|
|